Skip to Content
Merck
CN
  • Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells

British Journal of Cancer (2009)
Pichot CS, et al.